Panel recommends new, better shingles shot over old version


Make text smaller Make text larger



Photos





By MIKE STOBBE

A federal panel is recommending that older people vaccinated for shingles get a new, better shot approved in October.

The advisory panel said the vaccine made by GlaxoSmithKline works better than the first one made by Merck, which has been sold in the U.S. since 2006. Health officials say many as 20 million Americans should get a second round.

Shingles, a painful blistery condition, occurs when the chickenpox virus resurfaces later in life. Merck's vaccine is recommended for people 60 and older. But health officials say its effectiveness drops sharply after about five years.

The Advisory Committee on Immunization Practices said doctors should first opt for Glaxo's Shingrix, licensed last week, which uses a new ingredient to boost its effectiveness. It was recommended for people 50 and older.



Make text smaller Make text larger

Comments

Pool Rules



MUST READ NEWS

Girl Scouts give us a reason to keep running
By Geri Corey
— Exercising, especially going it alone, can be tiring, both physically and mentally. At times, the body and mind...

Read more »
Image

Chester considers changing to ward election system
By Frances Ruth Harris
— The town of Chester is considering changing to a ward election system.
At last week's board...

Read more »
Image

Emma Jorgensen, former GHS actor, to perform in 'Sketching the Soul'
By Geri Corey
— During her growing-up years, lifelong Goshen resident Emma Jorgensen spent a lot of down time reading books and...

Read more »
Image

Chester Public Library to hold volunteer fair
CHESTER — Are you required to do some volunteer work?
Looking join a group that shares your interests?
Need just a few hours...

Read more »
Image

VIDEOS



Subscribe to our mailing list

* indicates required
Community Newspapers


MOST READ

MOST COMMENTED



Find more about Weather in Chester, NY